Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Check your unrealized gains tab in TDA. You should see 100 shares listed there.
Thank you for your perspective. It’s greatly appreciated.
Thank you for the great summary.
Ugh. Well, thank you for the heads up.
Good call. Thank you. I went there and see the 100 shares listed there.
Interesting...my holdings in TDA were showing the old cusip number and old share amount. Now it’s removed the holding altogether.
Hahn just mentioned “monoclonal antibodies” in his opening statement as well.
Excellent. Thank you!!
Great post as always. Thank you.
I like your analysis. One other thought....it’s likely that CYDY would sell directly to the government and have them distribute to hospitals as they’re doing with Remdesivir. That will help reduce operational costs at least on the outset. Just my two cents...
The moderate to severe trial does have a built-in ready after 50 patients. My hope is that is the mild to moderate data and the 50 patient interim analysis are both stat. significant, that the FDA would approve it. Who knows....
Exactly...
Correct. He said it was “possible” but not definite.
Woohoo!!!
Nicely done!!!
Excellent!! Thank you!!
I agree. I hope they give updates on enrollment for both trials as that will define the schedule for data and readout...
Yes and those too!!!
I think it’s going to be a race between what happens first - complete data from the 75 patient mild/moderate trial or the interim 50 patient data from the moderate/severe trial. If we can updates on enrollment from both, it should give us some timeframes to work with.
I wonder if it’s Sanofi....given some of their history, it wouldn’t surprise me...
Well said and completely agree!!
Wow....great interview....asking for emergency approval with the data they submitted to the FDA today.
Whoa!! NP said they’re taking 7 day data and “asking for emergency approval, perhaps”.
Yes, they’re reporting now that he’s been moved into the ICU.....
It’ll be interesting to see what the FDA does with the phase 2b/3 interim analysis of data for the first 50 patients if the results are clearly positive....
Hoping NP provides updates on enrollment for the phase 2 (mild to moderate) and phase 2b/3 (moderate time severe) trials. Interesting that in the Yahoo finance video that was just shared, he refers to the second trial as a phase2b/3. Now we know.
On the radar:
1. Update on the COVID—19 patients 5 - 7.
2. FDA clearance for second Phase 2 trial for moderate to severe COVID-19 patients.
3. Update on cancer basket trial on both patients and enrollment.
If you start the video form the beginning, it starts at the -31:34 mark....hope this helps.
Fortunately, it’s only a $1.157 million dollars. Pretty tiny.....
I think data from 010 has a chance...the float is incredibly low.
I think it has to get current first but I could be wrong.
Great find!! Thx Sushi!!
Wishing you the best. Sending prayers your way...
Wow....literally just hit a few minutes ago. Great catch and thank you for posting!
Is it a motion to allow/uphold the US court ruling and have it be enforceable in Canada? I find it interesting that it is unopposed in this court as well....
Thank you. That would be fantastic.
LOL wish I knew but that’s ok. :) Will we find out tomorrow or will it wait until Monday?
Thank you for sharing this.
Yes. No sign of PAUL on the bid or ask today either. I could be crazy but I think that’s a good sign.....
I can’t help but think that’s a good sign....